respiratory syncytial virus vaccine bivalent recombinant

Italy

Drugs containing this active substance

  • ABRYSVO

    It is a vaccine used to prevent respiratory tract disease caused by respiratory syncytial virus (RSV). It is administered to pregnant women (to protect infants from birth up to 6 months of age) and to individuals aged 18 years and older.

    Form: solution for injection, powder and solvent

    Active substance Dosage
    respiratory syncytial virus vaccine bivalent recombinant -

    ATC: J07BX05

    Manufacturer: PFIZER EUROPE MA EEIG